Trial Details

COMPLETED
Basic Information
Clinical ID c1195
Identifier NCT01320332
Trial Title A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: ASP3291|DRUG: Placebo
Participant Information
Sponsor Telsar Pharma Inc.
City Anaheim
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-08-10
Primary Completion Date 2025-08-11
Completion Date 2025-08-11